Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colonic Neoplasms × Nivolumab × Clear all

Phase

Status

Completed 6 Active not recruiting 5 Recruiting 4 Terminated 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 22 Carcinoma, Non-Small-Cell Lung 22 Stomach Neoplasms 8 Neoplasms 6 Carcinoma, Renal Cell 6 Carcinoma, Hepatocellular 6 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Hodgkin Disease 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Mesothelioma, Malignant 2 Lymphoma, B-Cell 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Merkel Cell 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thymoma 1

Interventions

Fluorouracil 32 Leucovorin 29 Oxaliplatin 24 Irinotecan 17 Folfox protocol 11 Chemotherapy, Adjuvant 10 Capecitabine 10 Cetuximab 9 Neoadjuvant Therapy 8 Bevacizumab 8 XELOX 7 Drug Therapy 7 Laparoscopy 6 Endoscopic Mucosal Resection 5 Colonoscopy 4 Celecoxib 4 Radiotherapy 3 Preoperative Exercise 3 Gemcitabine 3 Curcumin 3 Colectomy 3 Aspirin 3 raltitrexed 2 Tegafur 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Sodium Chloride 2 Simvastatin 2 S 1 (combination) 2 Rivaroxaban 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03993626 2019-06-21

CAROSELL

Celleron Therapeutics Ltd.

Phase 1/2 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡